Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Health Enhanced Artery Risk Tracking With Widespread Implementation and Screening Effort in AtheroSclerotic CardioVascular Disease (HEARTWISE-ASCVD) Study

NCT07355894 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT07355894
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07355894 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Health Enhanced Artery Risk Tracking With Widespread Implementation and Screening Effort in AtheroSclerotic CardioVascular Disease (HEARTWISE-ASCVD) Study
Lead sponsor
Stanford University
Phase
Not applicable
Overall status
Not yet recruiting
Start date
May 31, 2026
Completion date
March 31, 2028
Enrollment
120,000 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

atherosclerotic cardiovascular disease (ascvd), coronary artery calcification